Antamanide antagonizes phalloidin-induced human lymphocyte aggregation and prevents leukaemic mice from death: a pilot study.
D000818:Animals; D002449:Cell Aggregation / Q000187:drug effects; D005260:Female; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008214:Lymphocytes / Q000187:drug effects*; D051379:Mice; D008806:Mice, Inbred AKR; D009842:Oligopeptides / Q000037:antagonists & inhibitors*; D010456:Peptides, Cyclic / Q000494:pharmacology* / Q000627:therapeutic use; D010590:Phalloidine / Q000037:antagonists & inhibitors*; D010865:Pilot Projects; D011446:Prospective Studies
D009842:Oligopeptides; D010456:Peptides, Cyclic; C100265:antamanide; D010590:Phalloidine